First Non-Invasive Technology For Treatment Of Uterine Fibroids Awarded MHLW Approval In Japan
InSightec Ltd. announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved the company’s ExAblate(R) MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with uterine fibroids. ExAblate is currently the only noninvasive treatment for uterine fibroids approved for use in Japan. Approximately 25% Japanese women will develop symptomatic uterine fibroids, primarily during childbearing years. These benign tumors can significantly impair functionality and degrade quality of life resulting in significant work absences.
For the full story, Click Here


The Blackpool Victoria Hospital has brought botox in use for the treatment of bladder problems. The cosmetic drug used to produce a smooth brow and wrinkle-free face is now being put to use in treating patients with overactive bladders. The response from patients has been good too. The procedure lasts for about 18 months and the effects are completely reversible.